Ignite Creation Date:
2024-05-05 @ 11:08 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01268553
Status:
COMPLETED
Last Update Posted:
2017-09-01
First Post:
2010-12-29
Brief Title:
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
Sponsor:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Organization:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Organization Data
Organization:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Class:
OTHER
Study ID:
Tyvaso Switch
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
ronald oudiz md
Responsible Party Title:
Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| United Therapeutics | INDUSTRY |